Transcription factors E2F1 and E2F3 are expressed in placenta but do not regulate MMP14

TJ Kaitu'u-Lino; R Hastie; P Cannon; H Nguyen; S Lee; NJ Hannan; S Tong

Journal article

Transcription factors E2F1 and E2F3 are expressed in placenta but do not regulate MMP14

TJ Kaitu'u-Lino, R Hastie, P Cannon, H Nguyen, S Lee, NJ Hannan, S Tong

Placenta | Published : 2015

DOI: 10.1016/j.placenta.2015.06.007

Abstract

Introduction Preeclampsia is a serious complication of pregnancy for which there are no efficacious medical treatments. Soluble endoglin is as an anti-angiogenic factor that contributes to the pathogenesis of the disease, however little is known about its molecular regulation in placenta. Recent data has demonstrated E2F transcription factors directly regulate MMPs in metastatic disease. Of particular interest was the capacity of E2F1 and E2F3 to up-regulate MMP14, a protease that cleaves and releases soluble endoglin from placenta. The aim of this study was to characterize E2F1 and E2F3 in preeclamptic placenta and assess whether silencing affects soluble endoglin release. Methods E2F1 and ..

View full abstract

University of Melbourne Researchers

Tu'uhevaha Kaitu'u-Lino Author

Ping Cannon Author

Natalie Hannan Author

Stephen Tong Author

Related Projects (4)

DEVELOPING MOLECULAR THERAPEUTICS AND DIAGNOSTICS FOR PREGNANCY COMPLICATIONS

Pregnancy complications still causes the death of mothers, and their babies. During this fellowship, we will be developing new treatments an..

TARGETING THE TOXINS OF PREECLAMPSIA

Preeclampsia is a severe disease of pregnancy - the placenta releases toxins in to mum's bloodstream that circulate her body and damage her ..

Soluble endoglin in the pathogenesis of preeclampsia: investigation of mechanisms and the development of therapeutics

Preeclampsia is a severe disease of pregnancy. As the pathogenesis is poorly understood, the only treatment is for clinicians to deliver bab..

Mother and baby communication during early pregnancy, the key to establishing a healthy pregnancy

Grants

Awarded by National Health and Medical Research Council

Funding Acknowledgements

The National Health and Medical Research Council of Australia provided salary (#1062418 to T.K, #628927 to N.H, #1050765 to S.T.) and project support (#1048707).